Financing type:  brokered private placement

Gross proceeds:  $17,250,046

Offering:  78,409,300 listed shares with 78,409,300 warrants attached

Offering price:  22 cents per listed share

Warrant exercise terms:  30 cents per listed share for a 30-month period

Commissions in securities:  Research Capital Corp. (lead) and a syndicate of underwriters, 4,650,558 warrants

Commission terms:  Each non-transferable warrant is exercisable at 22 cents for a 30-month period.

Disclosure:  Refer to the company's news releases dated March 3, 2026, March 4, 2026, and March 17, 2026.